Niki BioSolutions annual depreciation and amortization
2017
2018
2019
2020
2021
2022
2023
2024
2025
Niki BioSolutions Depreciation & Amortization Growth & History (NIKI)
Niki BioSolutions's depreciation and amortization was $0 for fiscal 2025.
View full Niki BioSolutions company overviewNiki BioSolutions annual depreciation and amortization history
| Fiscal year | Period ended | Depreciation and amortization | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $0 | −$255,046 | — |
| 2024 | 2024-12-31 | $255,046 | −$870,208 | −77.33% |
| 2023 | 2023-12-31 | $1.1M | −$82,256 | −6.81% |
| 2022 | 2022-12-31 | $1.2M | $14,932 | +1.25% |
| 2021 | 2021-12-31 | $1.2M | −$142,083 | −10.65% |
| 2020 | 2020-12-31 | $1.3M | $35,043 | +2.70% |
| 2019 | 2019-12-31 | $1.3M | $617,326 | +90.48% |
| 2018 | 2018-12-31 | $682,292 | $623,389 | +1058.33% |
| 2017 | 2017-12-31 | $58,903 | — | — |
Niki BioSolutions quarterly depreciation and amortization
Q3.24
| Fiscal quarter | Period ended | Depreciation and amortization | Change | YoY change |
|---|---|---|---|---|
| Q3 2024 | 2024-09-30 | $0 | — | — |
Niki BioSolutions depreciation and amortization trends
Over the last five fiscal years, Niki BioSolutions's depreciation and amortization decreased from $1.3M to $0, a change of −$1.3M. The latest reported quarter, Q3 2024, shows $0.
About the metric
What depreciation and amortization mean
Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.
Calculation and source
Reported depreciation and amortization
TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Niki BioSolutions source filings ↗